Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] SEL is in the business of manufacturing, distribution, marketing and selling of solvent extracted Rice Bran Oil and other by-products. Based on standalone financial data, it marked inconsistency in its top lines for the reported periods, but posted improved bottom lines. On consolidated basis, it marked growth in its top and bottom lines for the last two fiscals, however, boosted profits for FY25 appears to be a window dressing for fancy valuations. Based on its recent financial data, the issue appears aggressively priced. Small paid-up equity post-IPO indicates longer gestation period for migration. The Lead Manager has a poor track record. There is no harm in skipping this pricey and “High Risk/Low Return” bet. Read detail review...
Solvex Edibles Ltd. peer comparison with similar listed entities. (As on March 31, 2025)
| Company Name | EPS (Basic) | NAV (per share) (Rs) | P/E (x) | RoNW (%) | P/BV Ratio | Financial statements |
|---|---|---|---|---|---|---|
| Solvex Edibles Limited | 4.36 | 29.01 | 16.52 | 15.02 | 2.48 | Standalone |
| Ramdevbaba Solvent Limited | 6.88 | 69.31 | 18.44 | 9.92 | 1.83 | Standalone |
| MK Proteins Limited | 0.22 | 1.85 | 30.50 | 12.09 | 6.00 | Standalone |
Notes:
Solvex Edibles IPO Reviews, analysis and views by popular members. Read Solvex Edibles Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Note:
DRHP